INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 41h ago
House PTR1h ago
SEC 13F1h ago
Robinhood Chain1h ago

Most active filers · 30d

  1. 01Kurtz George0B / 217S · 10 late217 trades$54.77M
  2. 02SPSaba Capital Management, L.P.55B / 19S · 3 late74 trades$23.87M
  3. 03ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  4. 04CFCheng Chi Fung0B / 42S42 trades$15.33M
  5. 05RARothblatt Martine A0B / 33S33 trades$5.50M
  6. 06RJRubinstein Julie0B / 32S32 trades$5.55M
  7. 07LBLeach Bryan0B / 30S30 trades$7.97M
  8. 08AOAtay Oguzhan0B / 30S30 trades$7.55M
  9. 09JDJenkins William D Jr0B / 30S30 trades$13.38M
  10. 10BSBiswas Sanjit0B / 28S28 trades$22.33M

Cluster activity · 60d

  1. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  2. SELLFERGFerguson Enterprises Inc. /DE/Oct 12 – Oct 167 insiders$7.38M
  3. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
  4. BUYUPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M
  5. SELLIBEXIBEX LtdSep 14 – Sep 166 insiders$2.01M
  6. SELLARQQArqit Quantum Inc.Oct 2 – Oct 136 insiders$369K
  7. BUYBBTBeacon Financial CorpOct 26 – Oct 306 insiders$274K
  8. SELLBCYCBICYCLE THERAPEUTICS PLCOct 2 – Oct 56 insiders$63K

Form 4 transactions

21,251 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
31
WC
Walsh ColinDirector
ATTOAttovia Therapeutics, Inc.
Open-market sale
SELL$15K
700 sh
Aug 5, 2026Aug 13, 2026
Page 189 of 532
← PrevNext →
traded Aug 5, 2026
+8d
SEC Form 4

Evidence

31
RC
Raub ChristopherEVP JFI; CEO PPM America
JXNJackson Financial Inc.
Open-market sale
SELL$653K
5,000 sh
Aug 12, 2026Aug 13, 2026
traded Aug 12, 2026
+1dSEC Form 4

Evidence

31
WC
Walsh ColinDirector
ATTOAttovia Therapeutics, Inc.
Open-market sale
SELL$4,420
200 sh
Aug 5, 2026Aug 13, 2026
traded Aug 5, 2026
+8dSEC Form 4

Evidence

31
WC
Walsh ColinDirector
ATTOAttovia Therapeutics, Inc.
Open-market sale
SELL$9,649
443 sh
Aug 5, 2026Aug 13, 2026
traded Aug 5, 2026
+8dSEC Form 4

Evidence

31
WC
Walsh ColinDirector
ATTOAttovia Therapeutics, Inc.
Open-market sale
SELL$4,410
200 sh
Aug 5, 2026Aug 13, 2026
traded Aug 5, 2026
+8dSEC Form 4

Evidence

31
WC
Walsh ColinDirector
ATTOAttovia Therapeutics, Inc.
Open-market sale
SELL$2,199
100 sh
Aug 5, 2026Aug 13, 2026
traded Aug 5, 2026
+8dSEC Form 4

Evidence

31
WC
Walsh ColinDirector
ATTOAttovia Therapeutics, Inc.
Open-market sale
SELL$8,808
400 sh
Aug 5, 2026Aug 13, 2026
traded Aug 5, 2026
+8dSEC Form 4

Evidence

31
WC
Walsh ColinDirector
ATTOAttovia Therapeutics, Inc.
Open-market sale
SELL$29K
1,332 sh
Aug 5, 2026Aug 13, 2026
traded Aug 5, 2026
+8dSEC Form 4

Evidence

31
WC
Walsh ColinDirector
ATTOAttovia Therapeutics, Inc.
Open-market sale
SELL$22K
988 sh
Aug 5, 2026Aug 13, 2026
traded Aug 5, 2026
+8dSEC Form 4

Evidence

31
WC
Walsh ColinDirector
ATTOAttovia Therapeutics, Inc.
Open-market sale
SELL$4,410
200 sh
Aug 5, 2026Aug 13, 2026
traded Aug 5, 2026
+8dSEC Form 4

Evidence

31
WC
Walsh ColinDirector
ATTOAttovia Therapeutics, Inc.
Open-market sale
SELL$26K
1,180 sh
Aug 5, 2026Aug 13, 2026
traded Aug 5, 2026
+8dSEC Form 4

Evidence

31
WC
Walsh ColinDirector
ATTOAttovia Therapeutics, Inc.
Open-market sale
SELL$6,252
300 sh
Aug 5, 2026Aug 13, 2026
traded Aug 5, 2026
+8dSEC Form 4

Evidence

31
KJ
Kuai JeffGeneral Manager, Pizza Hut
YUMCYum China Holdings, Inc.
Open-market sale
SELL$253K
5,313 sh
Aug 12, 2026Aug 13, 2026
traded Aug 12, 2026
+1dSEC Form 4

Evidence

31
WC
Walsh ColinDirector
ATTOAttovia Therapeutics, Inc.
Open-market sale
SELL$10K
480 sh
Aug 5, 2026Aug 13, 2026
traded Aug 5, 2026
+8dSEC Form 4

Evidence

31
WC
Walsh ColinDirector
ATTOAttovia Therapeutics, Inc.
Open-market sale
SELL$15K
672 sh
Aug 5, 2026Aug 13, 2026
traded Aug 5, 2026
+8dSEC Form 4

Evidence

31
WC
Walsh ColinDirector
ATTOAttovia Therapeutics, Inc.
Open-market sale
SELL$34K
1,556 sh
Aug 5, 2026Aug 13, 2026
traded Aug 5, 2026
+8dSEC Form 4

Evidence

31
CE
Childers Jason E.SVP, Information Technology
WRLDWORLD ACCEPTANCE CORP
Open-market sale
SELL$381K
2,000 sh
Aug 12, 2026Aug 13, 2026
traded Aug 12, 2026
+1dSEC Form 4

Evidence

31
WC
Walsh ColinDirector
ATTOAttovia Therapeutics, Inc.
Open-market sale
SELL$26K
1,163 sh
Aug 5, 2026Aug 13, 2026
traded Aug 5, 2026
+8dSEC Form 4

Evidence

31
WC
Walsh ColinDirector
ATTOAttovia Therapeutics, Inc.
Open-market sale
SELL$9,776
447 sh
Aug 5, 2026Aug 13, 2026
traded Aug 5, 2026
+8dSEC Form 4

Evidence

31
WC
Walsh ColinDirector
ATTOAttovia Therapeutics, Inc.
Open-market sale
SELL$23K
1,040 sh
Aug 5, 2026Aug 13, 2026
traded Aug 5, 2026
+8dSEC Form 4

Evidence

31
WC
Walsh ColinDirector
ATTOAttovia Therapeutics, Inc.
Open-market sale
SELL$17K
753 sh
Aug 5, 2026Aug 13, 2026
traded Aug 5, 2026
+8dSEC Form 4

Evidence

31
WC
Walsh ColinDirector
ATTOAttovia Therapeutics, Inc.
Open-market sale
SELL$2,211
100 sh
Aug 5, 2026Aug 13, 2026
traded Aug 5, 2026
+8dSEC Form 4

Evidence

30
LC
Lightheart CharmaineEVP/CRDEO
RVSBRIVERVIEW BANCORP INC
Open-market purchase
BUY$1,327
250 sh
Aug 12, 2026Aug 13, 2026
traded Aug 12, 2026
+1dSEC Form 4

Evidence

29
MJ
Monroe Terilyn J.Chief People Officer
GHGuardant Health, Inc.
Open-market sale
SELL$605K
3,704 sh
Aug 12, 2026Aug 13, 2026
traded Aug 12, 2026
+1dSEC Form 4

Evidence

29
LG
Lucas Stephen GSVP, Culture and Engagement
KOPKoppers Holdings Inc.
Open-market sale
SELL$58K
1,308 sh
Aug 12, 2026Aug 13, 2026
traded Aug 12, 2026
+1dSEC Form 4

Evidence

29
MM
Mink Brook Asset Management LLC10% Owner
DLHCDLH Holdings Corp.
Open-market purchase
BUY$2,356
500 sh
Aug 12, 2026Aug 13, 2026
traded Aug 12, 2026
+1dSEC Form 4

Evidence

29
IN
Intrator Michael NDirector, CEO and President, 10% Owner
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$284K
3,120 sh
Aug 11, 2026Aug 13, 2026
traded Aug 11, 2026
+2dSEC Form 4

Evidence

28
AA
Ahmed AsmauDirector
QNSTQUINSTREET, INC
Open-market sale
SELL$104K
5,000 sh
Aug 11, 2026Aug 13, 2026
traded Aug 11, 2026
+2dSEC Form 4

Evidence

28
KJ
Kuai JeffGeneral Manager, Pizza Hut
YUMCYum China Holdings, Inc.
Open-market sale
SELL$237K
4,961 sh
Aug 12, 2026Aug 13, 2026
traded Aug 12, 2026
+1dSEC Form 4

Evidence

28
BL
Byers Deborah LDirector
KNTKKinetik Holdings Inc.
Open-market sale
SELL$141K
2,739 sh
Aug 12, 2026Aug 13, 2026
traded Aug 12, 2026
+1dSEC Form 4

Evidence

28
KJ
Kuai JeffGeneral Manager, Pizza Hut
YUMCYum China Holdings, Inc.
Open-market sale
SELL$206K
4,312 sh
Aug 12, 2026Aug 13, 2026
traded Aug 12, 2026
+1dSEC Form 4

Evidence

27
MP
McCarthy Cornelius P. IIIDirector
MEDPMedpace Holdings, Inc.
Open-market sale
SELL$690K
1,140 sh
Aug 11, 2026Aug 13, 2026
traded Aug 11, 2026
+2dSEC Form 4

Evidence

26
KV
Kuzoyan VaheDirector, President
TTANServiceTitan, Inc.
Open-market sale · 10b5-1 plan
SELL$4.39M
49.4K sh
Aug 11, 2026Aug 13, 2026
traded Aug 11, 2026
+2dSEC Form 4

Evidence

26
IN
Intrator Michael NDirector, CEO and President, 10% Owner
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$77K
845 sh
Aug 11, 2026Aug 13, 2026
traded Aug 11, 2026
+2dSEC Form 4

Evidence

26
IN
Intrator Michael NDirector, CEO and President, 10% Owner
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$55K
585 sh
Aug 11, 2026Aug 13, 2026
traded Aug 11, 2026
+2dSEC Form 4

Evidence

25
MM
Mink Brook Asset Management LLC10% Owner
DLHCDLH Holdings Corp.
Open-market purchase
BUY$2,256
471 sh
Aug 13, 2026Aug 13, 2026
traded Aug 13, 2026
+0dSEC Form 4

Evidence

25
TM
Thau Daniel MarkDirector
BLBDBlue Bird Corp
Open-market purchase
BUY$23K
350 sh
Aug 12, 2026Aug 13, 2026
traded Aug 12, 2026
+1dSEC Form 4

Evidence

24
AA
Ahmed AsmauDirector
QNSTQUINSTREET, INC
Open-market sale
SELL$204K
10.0K sh
Aug 12, 2026Aug 13, 2026
traded Aug 12, 2026
+1dSEC Form 4

Evidence

24
BP
Burnett PatrickSee Remarks
ARQTArcutis Biotherapeutics, Inc.
Open-market sale
SELL$220K
8,300 sh
Aug 11, 2026Aug 13, 2026
traded Aug 11, 2026
+2dSEC Form 4

Evidence

24
BP
Burnett PatrickSee Remarks
ARQTArcutis Biotherapeutics, Inc.
Open-market sale
SELL$175K
6,700 sh
Aug 12, 2026Aug 13, 2026
traded Aug 12, 2026
+1dSEC Form 4

Evidence